Cargando…
A protein-based smallpox vaccine protects non-human primates from a lethal monkeypox virus challenge
Concerns about infections caused by orthopoxviruses, such as variola and monkeypox viruses, drive ongoing efforts to develop novel smallpox vaccines that are both effective and safe to use in diverse populations. A subunit smallpox vaccine comprising vaccinia virus membrane proteins A33, B5, L1, A27...
Autores principales: | Buchman, George W., Cohen, Matthew E., Xiao, Yuhong, Richardson-Harman, Nicola, Silvera, Peter, DeTolla, Louis J., Davis, Heather L., Eisenberg, Roselyn J., Cohen, Gary H., Isaacs, Stuart N. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2939220/ https://www.ncbi.nlm.nih.gov/pubmed/20659519 http://dx.doi.org/10.1016/j.vaccine.2010.07.030 |
Ejemplares similares
-
Antibody against Extracellular Vaccinia Virus (EV) Protects Mice through Complement and Fc Receptors
por: Cohen, Matthew E., et al.
Publicado: (2011) -
Smallpox vaccine with integrated IL-15 demonstrates enhanced in vivo viral clearance in immunodeficient mice and confers long term protection against a lethal monkeypox challenge in cynomolgus monkeys
por: Zielinski, Rafal J., et al.
Publicado: (2010) -
Pharmacokinetics and Efficacy of a Potential Smallpox Therapeutic, Brincidofovir, in a Lethal Monkeypox Virus Animal Model
por: Hutson, Christina L., et al.
Publicado: (2021) -
Human monkeypox and smallpox viruses: genomic comparison
por: Shchelkunov, Sergei N., et al.
Publicado: (2001) -
The current emergence of monkeypox: The recurrence of another smallpox?
por: Lu, Tianyu, et al.
Publicado: (2022)